Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) filed its Monthly Return for Equity Issuer for the period ended 31 July 2026 with Hong Kong Exchanges and Clearing Limited on 4 August 2026.

• Stable share base: Issued ordinary shares stood unchanged at 837.10 million, with no treasury shares outstanding.

• Capital movements: The company reported no share issuances, repurchases, cancellations, option exercises, warrant conversions, or other equity-linked transactions during the month.

• Public float: Management confirmed compliance with the Main Board’s minimum public float requirement of 25% as at 31 July 2026.

• Governance affirmation: The filing includes standard confirmations that all regulatory, legal, and listing rule obligations related to securities matters have been met.

The absence of dilution events and the adherence to public float thresholds underscore the company’s stable capital structure over the reporting period.